PubMed:12975616 / 114-330
Annnotations
Glycosmos6-GlycoEpitope
{"project":"Glycosmos6-GlycoEpitope","denotations":[{"id":"T2","span":{"begin":0,"end":15},"obj":"http://www.glycoepitope.jp/epitopes/EP0086"},{"id":"T3","span":{"begin":88,"end":103},"obj":"http://www.glycoepitope.jp/epitopes/EP0086"}],"text":"Heparan sulfate that contains antithrombin binding sites is designated as anticoagulant heparan sulfate (HS(act)) since, in vitro, it dramatically enhances the neutralization of coagulation proteases by antithrombin."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":216},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":216},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Heparan sulfate that contains antithrombin binding sites is designated as anticoagulant heparan sulfate (HS(act)) since, in vitro, it dramatically enhances the neutralization of coagulation proteases by antithrombin."}